Description
CJC-1295 (No DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). In laboratory research environments, it has been studied for its interaction with growth hormone signalling pathways and pituitary receptor activation mechanisms.
Experimental investigations have examined CJC-1295 for its influence on growth hormone pulsatility signalling, insulin-like growth factor pathways, and endocrine regulatory mechanisms associated with metabolic and physiological research models.
The “No DAC” version refers to the absence of the Drug Affinity Complex modification, resulting in a shorter active window in experimental models and making it useful in research environments examining pulsatile hormone signalling patterns.
Research studies have also explored CJC-1295 in laboratory models focused on endocrine signalling, metabolic regulation, and growth hormone pathway activity.
Supplied as a lyophilised peptide powder in sterile laboratory research vials.
Contents: 5mg CJC-1295 (No DAC) per vial
For laboratory research use only.
Not intended for human consumption or therapeutic use.
Reviews
There are no reviews yet.